Reactive Arthritis: Treatment Challenges and Future Perspectives

Daniel Wendling1,2, Clément Prati3,4, Mickael Chouk3

  • 1Department of Rheumatology, CHRU de Besançon (University Teaching Hospital), Boulevard Fleming, 25030, Besançon, France. dwendling@chu-besancon.fr.

Abstract

Insights

Reactive arthritis, an infection-related synovitis, can lead to long-term disability. Early diagnosis and treatment with NSAIDs or DMARDs are crucial for managing this condition.

Area of Science:

  • Rheumatology
  • Immunology
  • Microbiology

Background:

  • Reactive arthritis is characterized by synovitis secondary to a distant infection.
  • Its clinical course is variable, ranging from self-limited episodes to chronic forms with functional impairment and sequelae.

Purpose of the Study:

  • To review recent findings in reactive arthritis, including etiological agents and pathophysiological mechanisms.
  • To discuss current and emerging treatment strategies for reactive arthritis.

Main Methods:

  • Literature review of microbiological and immunological studies.
  • Analysis of clinical data on treatment outcomes for reactive arthritis.

Main Results:

  • New microbiological agents have been implicated in reactive arthritis.
  • Pathophysiological insights highlight the role of mucosal immunity, specific cell populations, and pro-inflammatory cytokines.
  • Non-steroidal anti-inflammatory drugs (NSAIDs) are first-line treatments; synthetic and biological disease-modifying antirheumatic drugs (DMARDs) are used for refractory cases.
  • Available data suggest biological DMARDs offer good efficacy and safety.

Conclusions:

  • Reactive arthritis remains a significant clinical challenge.
  • Prompt diagnosis based on clinical presentation and history is essential for timely and appropriate treatment initiation.

Related Concept Videos

Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
209
Autoimmune Disorders01:29

Autoimmune Disorders

Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
1.3K
Psychosis: Goals of Pharmacotherapy01:26

Psychosis: Goals of Pharmacotherapy

Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
379
Drug Therapy01:28

Drug Therapy

The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
197
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
326
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
334